Please note that starting from 22 December 2022 the State Agency of Medicines has made changes in the Medicinal Product Register relating to the format of the published approved package leaflets and summaries of product...
The results of the survey conducted by the State Agency of Medicines (SAM) show that for medicines utilised in hospitals and other healthcare institutions electronic package leaflets are mostly used. Survey results are...
The State Agency of Medicines kindly informs that on 19 October 2022 from 9 am until 11 am the homepage of the Agency may not work (5 - 15 minutes) due to planned technical works. We apologize for the inconvenience!
Please note that starting from 7 September 2022 the State Agency of Medicines is transitioning to PDF (.pdf) format instead of the previous MS Word (.docx or .doc) format when publishing approved package leaflets...
The State Agency of Medicines has published its Annual Report of the year 2021 which summarizes information regarding the operation of the Agency during the previous year. Some of the numbers that show Agency’s...
The Clinical Trials Coordination Group (CTCG), set up by the Heads of Medicines Agencies, has developed recommendations for sponsors on the impact of the war in Ukraine on clinical trials. The Latvian Agency of Medicines...
In the context of the new Clinical Trials Regulation an informative presentation on Clinical Trials Information System (CTIS) has been prepared and is available here.
